within Pharmacolibrary.Drugs.C_CardiovascularSystem.C03D_AldosteroneAntagonistsAndOtherPotassiumSparingAgents.C03DA01_Spironolactone;

model Spironolactone
  extends Pharmacolibrary.Drugs.ATC.C.C03DA01;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>C03DA01</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Spironolactone is a potassium-sparing diuretic and an antagonist of aldosterone. It is primarily used to treat conditions such as heart failure, hypertension, primary hyperaldosteronism, and edema associated with liver cirrhosis or nephrotic syndrome. It is also used for treatment of hirsutism and acne in women. Spironolactone is an approved drug and is commonly used in clinical practice today.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult subjects following a single oral dose.</p><h4>References</h4><ol><li><p>Lass, J, et al., &amp; Lutsar, I (2024). Pharmacokinetics of oral spironolactone in infants up to 2 years of age. <i>European journal of clinical pharmacology</i> 80(2) 239–248. DOI:<a href=\"https://doi.org/10.1007/s00228-023-03599-w\">10.1007/s00228-023-03599-w</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/38041740/\">https://pubmed.ncbi.nlm.nih.gov/38041740</a></p></li><li><p>Regidor, PA, et al., &amp; Mayr, M (2023). Pharmacological and metabolic effects of drospirenone as a progestin-only pill compared to combined formulations with estrogen. <i>Women&#x27;s health (London, England)</i> 19 17455057221147388–None. DOI:<a href=\"https://doi.org/10.1177/17455057221147388\">10.1177/17455057221147388</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/36744531/\">https://pubmed.ncbi.nlm.nih.gov/36744531</a></p></li><li><p>Manjaly, C, et al., &amp; Mostaghimi, A (2023). Clascoterone for treatment of acne. <i>Drugs of today (Barcelona, Spain : 1998)</i> 59(2) 71–81. DOI:<a href=\"https://doi.org/10.1358/dot.2023.59.2.3507749\">10.1358/dot.2023.59.2.3507749</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/36811407/\">https://pubmed.ncbi.nlm.nih.gov/36811407</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Spironolactone;
